Tibenelast
Alternative Names: LY 172352; LY 186655Latest Information Update: 24 Aug 1994
At a glance
- Originator Eli Lilly and Company
- Class Anti-ischaemics; Antiasthmatics; Heart failure therapies
- Mechanism of Action Phosphoric diester hydrolase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Asthma